These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 2877851

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W, Wolf LM, Grotz W, Grieshaber M.
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
    Teshima D, Hino B, Makino K, Yano T, Itoh Y, Joh Y, Iida M, Oishi R.
    J Clin Pharm Ther; 2003 Jun; 28(3):239-42. PubMed ID: 12795783
    [Abstract] [Full Text] [Related]

  • 30. Sulphasalazine in the treatment of rheumatoid arthritis.
    Box SA, Pullar T.
    Br J Rheumatol; 1997 Mar; 36(3):382-6. PubMed ID: 9133974
    [No Abstract] [Full Text] [Related]

  • 31. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Azad Khan AK, Piris J, Truelove SC.
    Lancet; 1977 Oct 29; 2(8044):892-5. PubMed ID: 72239
    [Abstract] [Full Text] [Related]

  • 32. Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.
    Di Paolo MC, Paoluzi OA, Pica R, Iacopini F, Crispino P, Rivera M, Spera G, Paoluzi P.
    Dig Liver Dis; 2001 Oct 29; 33(7):563-9. PubMed ID: 11816545
    [Abstract] [Full Text] [Related]

  • 33. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
    Symmons DP, Salmon M, Farr M, Bacon PA.
    J Rheumatol; 1988 Apr 29; 15(4):575-9. PubMed ID: 2899645
    [Abstract] [Full Text] [Related]

  • 34. [Management of refractory and fulminating colitis].
    Turunen U.
    Duodecim; 1987 Apr 29; 103(14):890-6. PubMed ID: 3328677
    [No Abstract] [Full Text] [Related]

  • 35. Sulphasalazine in the long term management of rheumatoid arthritis.
    Bax DE, Amos RS.
    Drugs; 1986 Apr 29; 32 Suppl 1():73-6. PubMed ID: 2877858
    [Abstract] [Full Text] [Related]

  • 36. Sulphasalazine: a review of 40 years' experience.
    Watkinson G.
    Drugs; 1986 Apr 29; 32 Suppl 1():1-11. PubMed ID: 2877847
    [Abstract] [Full Text] [Related]

  • 37. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
    Cowan GO, Das KM, Eastwood MA.
    Br Med J; 1977 Oct 22; 2(6094):1057-9. PubMed ID: 21720
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM, Bartholomew TC, Jewell DP.
    Gut; 1981 Aug 22; 22(8):642-7. PubMed ID: 6116649
    [Abstract] [Full Text] [Related]

  • 39. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P.
    Aliment Pharmacol Ther; 1989 Apr 22; 3(2):183-91. PubMed ID: 2577483
    [Abstract] [Full Text] [Related]

  • 40. Lack of interaction between sulphasalazine and cimetidine in patients with rheumatoid arthritis.
    Pirmohamed M, Coleman MD, Galvani D, Bucknall RC, Breckenridge AM, Park BK.
    Br J Rheumatol; 1993 Mar 22; 32(3):222-6. PubMed ID: 8095423
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.